News | Computed Tomography (CT) | February 01, 2018

MedyMatch Receives FDA Device Designation for Intracranial Hemorrhage Software

Software designed to be highly sensitive to the presence of intracranial hemorrhage (ICH) and alert the treating physician when ICH is detected

MedyMatch Receives FDA Device Designation for Intracranial Hemorrhage Software

February 1, 2018 – MedyMatch Technology, a company focused on helping physicians provide accurate patient assessment through artificial intelligence (AI)-based insights, announced that it has been granted Expedited Access Pathway (EAP) designation by the United States Food and Drug Administration (FDA) for intracranial hemorrhage detection.

This software medical device, based on deep learning technologies, automatically analyzes non-contrast head computed tomography (CT) images.  It is designed to be highly sensitive to the presence of intracranial hemorrhage (ICH) in these scans and to alert the treating physician when ICH is detected.  Non-contrast head CT is the standard for initial assessment of potential ICH in emergency medicine settings. Accurate and timely detection of ICH is a critical step in clinical decision making for stroke assessment and head trauma.  

The EAP program is designed to facilitate rapid patient access to medical devices that demonstrate the potential to address unmet medical needs for life-threatening or irreversibly debilitating diseases or conditions. Under the 21st Century Cures Act, EAP devices will be transitioned to FDA's Breakthrough Device program.

MedyMatch has developed a broad machine vision and deep learning platform to support the assessment of multiple clinical indications. MedyMatch's team of AI, deep learning and machine vision experts is working with clinical and industry partners to yield unprecedented insights into medical data.  The first of these applications will be the detection of intracranial hemorrhage.  

For more information: www.medymatch.com

Related Content

Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis
News | Cardiovascular Ultrasound | April 16, 2019
DiA Imaging Analysis has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo...
Radiology Publishes Roadmap for AI in Medical Imaging
News | Artificial Intelligence | April 16, 2019
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future...
Sponsored Content | Videos | Information Technology | April 15, 2019
Vital Images has developed a strategy that allows its customers to capture revenues that are otherwise missed while b